What's new in the antibiotic pipeline-Reference-Cited by-同舟云学术

What's new in the antibiotic pipeline

Published:1999-10 Issue:5 Volume:2 Page:475-482
ISSN:1369-5274
Container-title:Current Opinion in Microbiology
language:en
Short-container-title:Current Opinion in Microbiology

Author:

Lee Ving J,Miller George H,Yagisawa Morimasa

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Microbiology

Reference86 articles.

1. L-084;Andes;Curr Opin Anti-infect Invest Drugs,1999

2. KR-21056;Morrissey;Curr Opin Anti-infect Invest Drugs,1999

3. CS-834;van Ogtrop;Curr Opin Anti-infect Invest Drugs,1999

4. DZ-2640, a new oral carbapenem antibiotic, 1: structure activity relationships and in vitro activity;Nishi,1995

5. DZ-2640, a new oral carbapenem antibiotic, 2: in vitro antimicrobial activity and β-lactamase stability of DU-6681, a parent compound of DZ-2640;Hohmura,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrolide, lincosamide, glycopeptide, and other antibacterial antibiotics;Medicinal Chemistry of Chemotherapeutic Agents;2023

2. Structural and Functional analysis of Staphylococcus aureus NADP-dependent IDH and its comparison with Bacterial and Human NADP-dependent IDH;Bioinformation;2014-02-19

3. Cloning, Expression, Purification and Characterization of UMP Kinase from Staphylococcus aureus;The Protein Journal;2012-04

4. Distinctive Attributes of β-Lactam Target Proteins in Acinetobacter baumannii Relevant to Development of New Antibiotics;Journal of the American Chemical Society;2011-11-28

5. Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa;Proceedings of the National Academy of Sciences;2010-12-06